We have identified a new basic helix-loop-helix (BHLH) DNA-binding protein, designated TEEC, which is
closely related to TFE3 and TFEB. The basic domain of TFEC is identical to the basic DNA-binding domain of TFE3 and TFEB, whereas the helix-loop-helix motif of TFEC shows 88 and 85% identity with the same domains in TFE3 and TFEB, respectively. Like the other two proteins, TlEC contains a leucine zipper motif, which has a lower degree of sequence identity with homologous domains in TFE3 and TFEB than does the BHLH segment. Little sequence identity exists outside these motifs. Unlike the two other proteins, TFEC does not contain an acidic domain, which for TFE3 mediates the ability to activate transcription. Like the in vitro translation product of TFE3, the in vitro-translated TFEC binds to the ipE3 DNA sequence of the immunoglobulin heavy-chain gene enhancer. In addition, the product of cotranslation of TFEC RNA and TFE3 RNA forms a heteromeric protein-DNA complex with tLE3 DNA. In contrast to TFE3, TFEC is unable to transactivate a reporter gene linked to a promoter containing tandem copies of the immunoglobulin ,uE3 enhancer motif. Cotransfection of TFEC DNA and TFE3 DNA strongly inhibits the transactivation caused by TFE3. TFEC RNA is found in many tissues ofadult rats, but the relative concentrations ofTFEC and TFE3 RNAs vary considerably in these different tissues. No TFEC RNA was detectable in several cell lines, including fibroblasts, myoblasts, chondrosarcoma cells, and myeloma cells, indicating that TFEC is not ubiquitously expressed.
Helix-loop-helix (HLH) proteins constitute a large family of transcription factors that serve a diversity of regulatory functions by binding to specific DNA sequences either as homodimers or as heterodimers (2-27, 30, 31, 33, 34, 36-40, 49) . These HLH proteins can be further classified into several subgroups based on their degree of sequence homology and their specific cellular roles (6) . The best characterized of these proteins are the members of the MyoD subgroup, which are expressed in myoblasts and myotubes and control skeletal muscle differentiation by directly activating a battery of muscle-specific genes (reviewed in reference 35) . Members of the MyoD family interact with another group of related, ubiquitously expressed HLH proteins, E12 and E47, to form heterodimers that bind to specific DNA sequences in regulatory segments of muscle-specific genes (9, 15, 16, 35, 37, 49) . Like the MyoD subgroup, members of the Achaete-Scute subgroup control differentiation of the peripheral nervous system during embryonic development in Drosophila melanogaster and form heterodimers with the product of the ubiquitously expressed gene Daughterless (10, 13, 46) .
The product of the proto-oncogene c-myc, whose role in the control of cellular proliferation in mammalian cells has been well documented, is another HLH protein (2, 6, 31) . Myc forms a heterodimer with its HLH partner, Max, and Myc-Max heterodimers bind much more strongly to their DNA target sequences than do Myc homodimers (7, 36) .
All HLH proteins that bind to DNA recognize a core DNA sequence CANNTG through a domain rich in basic residues located immediately N terminal to the HLH domain (6, 31) .
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Members of different subfamilies can distinguish between each other's target sequences by recognizing specific bases at the two central positions and residues surrounding the hexamer binding site. One class of HLH proteins, the Id group (6, 14, 17, 19, 44) , lacks the basic DNA-binding domain; heterodimers between Id and other HLH proteins such as MyoD and E12 lack the ability to bind DNA. Hence, the ability of HLH proteins to form both active and inactive heterodimers provides these proteins with a wide regulatory diversity (6, 32) .
The transcription factors TFE3 and TFEB form a separate subgroup of HLH proteins. TFE3 was identified as a protein that is able to bind to the p,E3 motif of the immunoglobulin heavy-chain gene enhancer (4) . TFEB was similarly isolated as a protein that binds to a site in the proximal adenovirus major late promoter (12) . TFE3 and TFEB bound to DNA both as homodimers and as TFE3-TFEB heterodimers (18) , and TFE3 was showr Eo stimulate the expression of a reporter gene fused to a DNA segment in which several copies of the ,uE? sequences were positioned upstream of a minimal promot.:r (4). This transactivation appeared to be largely dependent on an acidic domain located N terminal to the basic HLH (BHLH) region (4) . TFE3 and TFEB, which are expressed in many different cell lines and tissues, do not form heterodimers with members of other known HLH subfamilies (18) .
We have identified a new member of the TFE3-TFEB group, designated TFEC. A 132-bp TFEC cDNA fragment corresponding to the BHLH region was obtained from a rat chondrosarcoma tumor cDNA preparation by using the polymerase chain reaction (PCR) with oligonucleotide primers derived from the BHLH region of human TFE3. A 1.6-kb TFEC cDNA was isolated by screening a rat chondrosarcoma tumor cDNA library with use of the PCR-generated TFEC cDNA fragments. Its deduced amino acid sequence shows a high degree of identity with TFE3 and TFEB throughout the BHLH domain and an adjacent leucine zipper segment. The in vitro translation product of TFEC RNA bound the ,uE3 DNA motif both as a homodimer and as a heterodimer with TFE3. Unlike TFE3, TFEC was unable to transactivate a reporter gene linked to a reconstituted promoter containing tandem copies of ,uE3 DNA. When cotransfected together with TFE3, however, TFEC strongly inhibited the transactivation produced by TFE3.
MATERIALS AND METHODS RNA isolation. Total RNA from different tissues and cell lines was purified by guanidine thiocyanate-cesium chloride centrifugation and phenol-chloroform extraction. mRNA was isolated by two rounds of chromatography over oligo(dT)-cellulose type II (Collaborative Research).
PCRs and cloning. PCR primer P1, 5'-AACCACAACC(T) TG(A/C/T)ATC(A/T)GA-3', was designed on the basis of the amino acid sequence in the basic domain of TFE3, NHN LIE, whereas PCR primer P2, 5'-CACGGAGGCT(C)TTC (A/G/T)AA(G)T(A/G)AT-3', was designed as the antisense oligonucleotide on the basis of the amino acid sequence in helix 2 of TFE3, ILKASV. The oligonucleotides were synthesized with an Applied Biosystems model 391 PCR-Mate DNA synthesizer. PCRs were performed, using first-strand cDNA from a rat chondrosarcoma mRNA preparation as the template and using P1 and P2 as primers, in a volume of 100 ,ul containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2, deoxynucleoside triphosphates at 200 ,uM each, and 2.5 U of AmpliTaq polymerase. Mineral oil (60 RI) was added to cover the reaction mixtures. Thirty to thirty-five cycles of amplification were carried out at 94°C for 1 min, 50°C for 2 min, and 72°C for 2 min. The PCR products were cloned into the EcoRV site of pBluescripts KS II(+) (Stratagene). Sequencing was performed by the dideoxynucleotide termination method (41) .
Isolation of TFEC cDNA. cDNA was synthesized with oligo(dT) as the primer, using a rat chondrosarcoma mRNA as the template, essentially according to a published method (1, 42) , with the minor modification that the double-stranded cDNAs were fractionated by a 1% agarose gel electrophoresis. After elution from the gel, cDNAs larger than 500 bp were ligated to BstXI adaptors, and the cDNAs were then cloned into a modified pBluescript KS II(+) plasmid. In this plasmid, the existing BstXI site was replaced by two new BstXI sites compatible with the adaptors and also with those in the mammalian expression vector pCDM8 (Invitrogen). A total of 106 bacterial colonies containing the cDNA library were transferred to nitrocellulose filters (Schleicher & Schuell). Hybridizations were performed at 65°C overnight in 5x SSPE (lx SSPE is 0.18 M NaCl, 10 The rat TFEC cDNA was released from pBluescript by cleavage at the HindIII and Notl sites located in the polylinker region and inserted into pCDM8 between the HindIII and NotI sites (pTFEC). The reporter gene plucE4 was generated by cloning the adenovirus major late minimal promoter from -46 to +10 into the HindIII site of the promoterless pA31uc vector (48) , followed by the insertion of four tandem repeats of the ,uE3 motif (4) in the SmaI site of pA31uc, 5' to the insertion site of the major late promoter. The sequence of the minimal major late promoter lacks the binding site for the upstream stimulatory factor. Plasmid pA31uc contains the firefly luciferase gene as a reporter gene. TFEC-250 was generated by inserting a 250-bp fragment of rat TFEC DNA (nucleotides 853 to 1103) between the KpnI and PstI sites of the polylinker in pBluescript. TFE3-378 was created by inserting a 378-bp PCR fragment of rat TFE3 DNA (corresponding to nucleotides 315 to 693 of human TFE3) into the EcoRV site of pBluescript. Both TFEC-250 and TFE3-378 were used to generate probes for RNase protection experiments. Cell culture, transfection, and luciferase assays. COS-1 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. The DNA transfection experiments were carried out by using electroporation with a Gene Pulser (Bio-Rad). For each electroporation, 3 x 106 COS-1 cells, 2 ,ug of reporter plasmid DNA, and 15 ,ug of expression vector DNA were added. Electroporation was performed at 330 V and 125 ,uF in a volume of 100 ,ul of phosphate-buffered saline. Luciferase assays were performed according to Wood et al. (48) . DNA transfection experiments were repeated four times, and essentially identical results were obtained in each experiment.
DNA binding assay. Both pTFE3 DNA and pTFEC DNA were linearized by Notl. In vitro transcription was performed with T7 RNA polymerase by using the mRNA capping kit (Stratagene catalog no. 200350) with 1 jig of linearized DNA template. In vitro translations and cotranslations were performed by using rabbit reticulocyte lysate (Promega catalog no. L4960) in a reaction volume of 30 RI. The ,uE3 motif oligonucleotides used for electrophoretic mobility shift assays were identical to those used by Beckmann et al. (4) . The double-stranded DNA probe was labeled with [a(-32P]dGTP and the Klenow enzyme and was separated from free nucleotides by gel electrophoresis. For each DNA-binding reaction, 2 pl of the in vitro translation reaction mixture and 5 x 105 cpm of double-stranded oligonucleotide probe were mixed in 10 RI of binding buffer containing 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.9), 50 mM KCI, 10% glycerol, 0.5 mM dithiothreitol, 1 jig of poly(dI-dC), 0.5 mM phenylmethanesulfonyl fluoride, 0.05% Nonidet P-40, and 1 mM EDTA. For competition experiments, a 100or 1,000-fold excess of unlabeled double-stranded oligonucleotides was included in the binding reaction. Electrophoresis was carried out in a 5% polyacrylamide gel, using 0.5 x Tris-borate-EDTA as the running buffer.
Expression of TFEC. For Northern (RNA) hybridization, 10-,ug samples of poly(A)+ RNA from a rat chondrosarcoma tumor ( Fig. 4A ) and several cell types (data not shown) were fractionated on a formaldehyde agarose gel (1%) and transferred to a GeneScreen Plus membrane (Schleicher & Schuell). Prehybridization was performed in 5 x SSPE-10 x Denhardt's solution-200 jig of denatured and sheared herring sperm DNA per ml-0.5% SDS at 60°C for 16 h. Hybridization was performed in Sx SSPE-5x Denhardt's solution-200 jig of denatured and sheared herring sperm Ten micrograms of total RNA from each rat tissue and/or cell type was used for hybridization. The assay was performed by using the RPAII RNase protection kit (Ambion catalog no. 1410). Chromosome mapping. In situ hybridization experiments were carried out by using metaphase spreads from a male mouse of the WMP/pas strain, in which all autosomes except 19 were in the form of metacentric Robertsonian translocations. WPM/pas is an inbred strian derived from Mus musculus domesticus. Concanavalin A-stimulated lymphocytes were cultured at 37°C for 72 h, with 5-bromodeoxyuridine added for the final 6 h of culture (60 ,ug/ml of medium) to ensure a chromosomal R banding of good quality.
The rat TFEC cDNA released from plasmid pTFEC was tritium labeled by nick translation to a specific activity of 9.4 x 107 dpml,pg. The radiolabeled probe was hybridized to metaphase spreads at a final concentration of 12 ng/ml of hybridization solution as previously described (29) .
After being coated with nuclear track emulsion (Kodak NTB2), the slides were exposed for 15 days at 4°C and then developed. To avoid any slipping of silver grains during the banding procedure, chromosome spreads were first stained with buffered Giemsa solution; the metaphases were then photographed. R banding was then performed by the fluorochrome-photolysis-Giemsa method, and metaphases were rephotographed before analysis.
Nucleotide sequence accession number. The rat TFEC cDNA sequence shown in Fig. 1 has been submitted to GenBank. The accession number is L08812.
RESULTS
Isolation and sequence analysis of TFEC cDNA. Using primers P1, which was derived from the amino acid sequence of the basic domain of TFE3, and P2, which was derived from the amino acid sequence of helix 2 of TFE3 (see Materials and Methods), and a rat chondrosarcoma cDNA preparation as the template, we generated a 132-bp DNA fragment by PCR. Although the deduced amino acid sequence of this 132-bp fragment showed a high degree of identity with similar segments in human TFE3 and human TFEB, enough differences existed to suggest that it was derived from a different mRNA.
We subsequently cloned a segment 3' and another segment 5' to this 132-bp DNA from a rat chondrosarcoma cDNA library by PCR using primers derived from the 132-bp DNA sequence and vector primers. The 3' PCR experiment generated one major cDNA of approximately 1.1 kb, which was cloned, and a larger cDNA of approximately 2.5 kb. The 5' PCR gave one major cDNA product of about 600 bp and several minor species of smaller size. The 1.1-kb and 600-bp DNAs were then used to screen the same rat chondrosarcoma cDNA library by colony hybridization, resulting in the isolation of a 1.6-kb cDNA. The sequence of this 1.6-kb DNA revealed an open reading frame of 317 amino acids starting from an in-frame methionine codon (Fig. 1) .
In the sequence shown in Fig. 1 , five other AUG codons precede the predicted AUG initiation codon, but all five of these AUGs are followed within a short distance by in-frame termination codons. Three additional in-frame AUG codons also appear in the cDNA sequence within the first 95 codons of the larger open reading frame. It is possible that some of these internal initiation codons are used, since in vitro translation of TFEC RNA showed three polypeptides, the largest of which corresponded in size to the 317-amino-acid open reading frame in Fig. 1 (data not shown). The sequences surrounding all these initiation codons, except for one of the upstream AUGs, diverge from the consensus translation initiation codon described by Kozak (28) . The role of these various AUG codons in controlling translation of TFEC RNA has not been examined.
TFEC is a member of the TFE3 subfamily of BHLH transcription factors. Part of the deduced amino acid sequence in Fig. 1 showed a high degree of identity with the BHLH and leucine zipper motifs of TFE3 and TEEB (Fig.  2) . Between residues 107 and 123, this sequence is identical to the amino acid sequences of the basic domains of TFE3 and TFEB. In these proteins as well as in other BHLH proteins, this basic motif represents the DNA-binding domain (6) . The sequence immediately downstream of the basic domain in Fig. 1 is consistent with that of a helix-loophelix motif and shows 85 a,id 88% identity with the HLH motifs of TFEB and TFE3, respectively. The distal part of the loop and helix 2 are identical in all three proteins. Finally, the amino acid sequence between residues 172 and 205 contains four leucine repeats seven residues apart. The amino acid sequence of this segment in Fig. 1 II II II II II:1  III III II.11I: : I1 11 TFEB. Very little sequence homology exists, however, between this new polypeptide and the other two proteins outside the BHLH and leucine zipper motifs. Given the sequence homology with TFE3 and TFEB, the polypeptide encoded by this new cDNA was designated TFEC. We further noted that the acidic domain present in both TFE3 and TFEB upstream of the BHLH domain was absent in TFEC. This segment has transcriptional transactivation property in TFE3 (4).
To determine whether alternative splicing could occur within the cDNA encoding the amino acid sequence in Fig.  1 , we performed a PCR experiment using as the sense primer the sequence surrounding the predicted AUG initiation codon and as the antisense primer a sequence at the 3' end of the 1.6-kb cDNA. With a chondrosarcoma tumor cDNA preparation used as the template, a single 1.4-kb DNA species was produced. This 1.4-kb cDNA was cloned into pBluescript, and the sequence of the DNA insert was determined for three individual colonies from three different PCRs. All three inserts showed the same sequence as the one shown in Fig. 1 . This experiment strongly suggested that within the segment defined by the primers, no major alternative spliced RNAs were produced. TFEC binds the ,E3 DNA sequence as a dimer. Plasmids pTFEC and pTFE3 were linearized by NotI digestion for in vitro transcription and translation. Since the basic domain of TFEC is identical to those of TFE3 and TFEB, we anticipated that TFEC would recognize the same target DNA sequences. The DNA-binding activities of TFE3 and TFEC to p,E3 DNA were, therefore, compared. As shown in Fig. 3 , the in vitro translation products of both TFE3 and TFEC bound to the p,E3 sequence. The mobility of the TFEC-DNA complexes was clearly higher than that of the TFE3-DNA complexes, presumably a reflection of the differences in molecular weights of the two polypeptides ( Fig. 3 ; compare lane 2, indicated by arrow A, and lane 5, indicated by arrow C).
As can be seen in lane 5 of Fig. 3 , the TFEC-DNA complex migrated as a broad band. This could have been due to the fact that the in vitro translation products of TFEC RNA migrated as three discrete polypeptide species in SDS-polyacrylamide gel electrophoresis (data not shown), which may correspond to different in-frame translation initiations of TFEC RNA. Such internal initiation may indeed take place, since the context of the 5'-proximal AUG does not conform well to the consensus sequence for translation initiation (28) . Hence, the broad band corresponding to the TFEC-DNA complex in Fig. 3 
was probably the result of complexes between DNA and various homoand heteromeric forms of the TFEC polypeptides.
A protein which is endogenous to the reticulocyte lysate formed a complex with ,uE3 DNA (Fig. 3, lane 1) . Binding of TFE3 and TFEC to labeled ,E3 DNA was inhibited by excess of unlabeled oligonucleotides containing the ,uE3 sequence. Interestingly, when TFE3 and TFEC RNAs were cotranslated, the products of translation bound to ,uE3 DNA with an intermediate mobility in gel shift assays (Fig. 3 , lane 8, indicated by arrow B). No such intermediate species was seen when the translation products of separate reactions, each containing either TFEC or TFE3, were mixed after translation was completed (data not shown). The intensity of the complex with intermediate mobility was more pronounced than that corresponding to the TFE3-DNA or TFEC-DNA complexes. Since the amounts of TFEC and TFE3 polypeptides present in the cotranslation mixture were approximately equal, this experiment suggests either that A represents the complex between the probe and TFE3; B is the complex between DNA and the TFE3-TFEC heteromer; C represents the TFEC-DNA complex; D corresponds to a complex between the probe and a DNA-binding protein present in the reticulocyte lysate.
TFEC and TFE3 preferentially form heterodimers or that the heterodimers bind to DNA more efficiently than do the TFEC or TFE3 homodimers in vitro. The relative levels of TFEC and TFE3 were determined in a separate cotranslation reaction by autoradiographic comparison of the [35S] methionine-labeled polypeptides (data not shown).
The results of Fig. 3 indicate that TFEC and TFE3 bound as homodimers, as previously shown for TFE3 (4) , and that the products of TFE3 and TFEC RNA cotranslation formed complexes with DNA in which TFEC was mainly present as a heterodimer with TFE3. Since cotranslation was required to form a heteromeric-DNA complex, it is likely that once homodimers were formed, they did not dissociate at a high enough rate to form heterodimers.
TFEC lacks transactivation ability and inhibits TFE3-dependent transactivation. Since TFEC lacks the acidic domain, which is responsible for transactivation in the case of TFE3 (4), it was possible that TFEC also lacks the ability to transactivate transcription. The cDNAs for rat TFEC and human TFE3 were cloned into the pCDM8 mammalian expression vector, and their transactivation properties were tested in COS-1 cells by cotransfection with the plucE4 reporter gene, which contains four tandemly repeated ,uE3 DNA sequences placed upstream of a minimal adenovirus a COS-1 cells were transfected with the indicated plasmids by electroporation, and cells were harvested 48 h after DNA transfection. pCDM8 is the expression vector in which TFE3 DNA and TFEC DNA were cloned. A 0.1g amount of pSV21acZ DNA was added in each transfection to normalize for transfection efficiency. Luciferase assays were performed according to Wood et al. (48) . Values are from duplicate transfection experiments and are expressed in arbitrary units relative to ,B-galactosidase activities.
major late promoter driving the firefly luciferase gene. As shown previously (4), TFE3 is a strong transcriptional activator when cotransfected with the reporter gene plucE4 in COS-1 cells ( Table 1 ). In contrast, TFEC was unable to transactivate the same reporter gene despite the fact that TFEC bound to the ,uE3 motif in vitro. Experiments in which TFEC DNA and TFE,3 DNA were transfected together showed a marked reduction in the transactivation caused by TFE3. Increased amounts of TFEC DNA in the cotransfection mix led to a greater decrease in the activity of the reporter gene.
Tissue distribution of TFEC. Northern hybridization showed that two species of TFEC RNA, 1.6 and 3.0 kb, exist in a rat chondrosarcoma tumor (Fig. 4A ). TFEC RNA was not detected in preparations isolated from several cell types. These cells included WT 2.7, which was derived from a mouse chondrosarcoma tumor (47) , mouse 1OT1/2 and NIH 3T3 fibroblasts, mouse C2 myoblasts, and mouse myeloma S194 cells (data not shown). We also used an RNase protection assay to compare TFEC and TFE3 RNA levels in different rat cell types and tissues (Fig. 4B ). No TFEC RNA was detected in a rat chondrosarcoma cell line (a generous gift of J. Kimura, Henry Ford Hospital, Detroit, Mich.) or in newborn rat rib chondrocytes, whereas low levels of TFEC RNA were found in 14-day rat embryos and in 18-day rat embryo skeletal tissues. In tissues of 8-week-old rats, we found relatively high levels of TFEC RNA in RNA preparations of kidney, spleen, and lung tissues, lower levels in liver, testis, and muscle tissues, and even less in other tissues. In contrast to TFEC RNA, TFE3 RNA was much more ubiquitously and evenly expressed in various cell types and tissues (Fig. 4B) .
Chromosome mapping. TFEC DNA was mapped by in situ hybridization to the E4-G region of chromosome 2 of the mouse genome (Fig. 5 ). Numerous other genes but no other known BHLH genes map to this chromosomal segment.
DISCUSSION
Transcriptional control plays a central role in determining the levels of gene expression in various tissues at different stages of development and differentiation. Such regulation is dependent on cooperative interactions between transcriptional activators and inhibitors as well as on the general components of the transcription machinery. Here we de- scribe the molecular cloning and characterization of a cDNA encoding TFEC, a new member of the multigene HLH family of DNA-binding proteins. The 1.6-kb cDNA sequence (Fig. 1 ) contains a polyadenylation signal at its 3' end and probably corresponds to the approximately 1,600-nucleotide-long RNA observed by Northern hybridization. This 1.6-kb cDNA encodes a 317amino-acid polypeptide, which presumably represents the complete TFEC protein. A large portion of the sequence directly preceding the postulated translation initiation codon (Fig. 1 ) was also found in another TFEC cDNA clone. However, we cannot exclude the possibility that some of the 5' untranslated sequences shown in Fig. 1 are intron sequences and that additional different 5' untranslated sequences are present in TFEC mRNA. We also do not know whether the additional sequences in the larger 3-kb RNA species, identified by Northern hybridization, represent 5' or 3' sequences. A 2.5-kb DNA, in addition to a 1.1-kb DNA that corresponds to the 3' portion of the sequence presented in Fig. 1, was reproducibly identified by PCR experiments which utilized a rat chondrosarcoma tumor cDNA library as the template and three nested primers corresponding to the BHLH domain of TFEC (between nucleotides 570 and 600 in Fig. 1 ) in combination with a vector primer. This finding suggested that the difference between the 1.6-kb RNA species and the 3-kb RNA species could be due to additional 3' untranslated sequences.
TFEC showed the same arrangement of three characteristic domains, a basic domain, an HLH domain, and a leucine zipper domain, found in several other HLH proteins such as the Myc proteins, Max (7, 36), the upstream stimulatory factor (20) , AP4 (23), TFE3 (4), and TFEB (12) . The basic domain of TFEC is identical to those of the other two DNA-binding proteins of this family, TFE3 and TFEB. Since this domain is responsible for specific DNA binding, it was not surprising that TFEC bound to the same DNA sequence as did TFE3 and TFEB. These three proteins also show a high degree of sequence identity in the HLH and leucine zipper regions. Like TFE3 and TFEB, which bind to their target DNA both as homodimers and as TFE3-TFEB heterodimers (4, 18) , TFEC bound to DNA either as a homodimer or as a heterodimer with TFE3. We have not yet tested whether heterodimers can also be formed between TEEC and TFEB.
The deduced amino acid sequence of TFEC shows that it lacks a domain rich in acidic residues. This acidic domain was shown to mediate transcriptional transactivation in TFE3 (4) . An isoform of TFE3 called smTFE3, which is the product of an alternatively spliced TFE3 RNA, lacks the acidic domain present in TFE3 and has a reduced ability to transactivate transcription of a reporter gene (38, 39) . Our results indicate that TFEC completely lacks the ability to transactivate transcription of a reporter gene in which four tandem copies of the pE3 DNA sequence are positioned upstream of a minimal promoter. This result and the analogy with smTFE3 raised the possibilities that the amino acid sequence of TFEC presented in Fig. 1 also results from an alternatively spliced form of TFEC and that another isoform of TFEC that contains an acidic activation domain similar to I MOL. CELL. BIOL. the one present in TFE3 exists. We have argued that the 1.6-kb DNA sequence presented in Fig. 1 corresponds to the 1.6-kb RNA species observed by Northern hybridization and that the 3-kb RNA species contains additional 3' untranslated sequences. Although we have found no evidence for other alternatively spliced TFEC RNAs among the TFEC cDNAs that we have generated, we cannot exclude their existence in cDNAs from other tissues.
TFEC also inhibited the transactivation by TFE3 of a reporter gene in cotransfection experiments. This inhibition could be accounted for by at least two models. Since TFEC bound to the ,uE3 motif as a heterodimer with TFE3 in vitro, the presence of TFEC in the heterodimer could alter the protein-protein interactions which made it possible for the acidic domain of TFE3 to interact with other components of the transcriptional machinery and to activate transcription when TFE3 bound as a homodimer to promoters. Alternatively, the inhibition of TFE3 transactivation could be due to the presence of TFEC homodimers which would compete for binding of TFE3 homodimers and TFE3-TFEC heterodimers; in this model, the TFEC-TFE3 heterodimer would still be able to activate a target promoter but less efficiently than TFE3 homodimers. Our experiments do not allow us to distinguish between these two models. We also cannot rule out the possibility that TFEC also functions as a transcriptional activator in other promoters under different conditions. Indeed, other transcription factors such as YY1 can either activate or inhibit transcription, depending on the position of the DNA-binding site in the promoter (43) .
The precise biological roles of TFE3 and TFEB are unknown. A comparison of the TFEC and TFE3 expression patterns in various tissues revealed significant differences in the relative levels of these two RNAs. Furthermore, the levels of TFEC RNA were higher in kidney, lung, and spleen tissues than in other tissues. We noted that TFEC RNA was undetectable in a well-differentiated chondrosarcoma cell line and in rib chondrocytes, whereas TFEC RNA was present in the rat chondrosarcoma tumor from which the TFEC cDNA was isolated. This finding suggests that in the chondrosarcoma tumor TFEC RNA was present in nonchondrocytic cells.
Whatever its role may be, the existence of this new HLH protein adds to the complexity of the mechanisms by which the TFE3 family of transcription factors controls gene expression.
